Remdesivir Gets Lukewarm Endorsement From Experts in Covid Fight

(Bloomberg) -- Gilead Sciences Inc.’s remdesivir is worth prescribing for patients with severe Covid-19 though evidence of its benefits remains inconclusive, according to a panel of international e...